Novel PAK4 pathways to drive cancer cell invasion; opportunities for targeted therapy

被引：0
|
作者：
Nicholas, Nicole [1 ]
King, Helen [1 ]
Thillai, Kiruthikah [1 ]
Pipili, Aikaterini [1 ]
Lesjak, Michaela [1 ]
Wells, Claire M. [1 ]
机构：
[1] Kings Coll London, Div Canc Studies, London SE1 1UL, England
来源：
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE | 2017年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：S8 / S8
页数：1
相关论文
共 50 条
  • [31] DGCR6L, a novel PAK4 interaction protein, regulates PAK4-mediated migration of human gastric cancer cell via LIMK1
    Li, Xiaodong
    Ke, Qiang
    Li, Yanshu
    Liu, Funan
    Zhu, Ge
    Li, Feng
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2010, 42 (01): : 70 - 79
  • [32] Novel PAK4 allosteric modulators (PAMs) provide potential therapeutic options in human gastric cancer
    Chien, Wenwen
    Xiao, Jinfen
    Ding, Ling -Wen
    Muzakar, Muhammad Ikhsan B.
    Sun, Qiao-Yang
    Gery, Sigal
    Senapedis, William
    Shacham, Sharon
    Baloglu, Erkan
    Koeffler, H. Phillip
    CANCER RESEARCH, 2015, 75
  • [33] Enhancing immune checkpoint blockade therapy is achieved through inhibition of PAK4
    Kim, S. M.
    FEBS OPEN BIO, 2024, 14 : 276 - 276
  • [34] PAK4 Phosphorylates Fumarase and Blocks TGFβ-Induced Cell Growth Arrest in Lung Cancer Cells
    Chen, Tao
    Wang, Ting
    Liang, Wenhua
    Zhao, Qin
    Yu, Qiujing
    Ma, Chun-Min
    Zhuo, Lingang
    Guo, Dong
    Zheng, Ke
    Zhou, Chengzhi
    Wei, Shupei
    Huang, Wenhua
    Jiang, Juhong
    Liu, Jing
    Li, Shiyue
    He, Jianxing
    Jiang, Yuhui
    Zhong, Nanshan
    CANCER RESEARCH, 2019, 79 (07) : 1383 - 1397
  • [35] PAK4 suppresses PDZ-RhoGEF activity to drive invadopodia maturation in melanoma cells
    Nicholas, Nicole S.
    Pipili, Aikaterini
    Lesjak, Michaela S.
    Ameer-Beg, Simon M.
    Geh, Jenny L. C.
    Healy, Ciaran
    Ross, Alistair D. MacKenzie
    Parsons, Maddy
    Nestle, Frank O.
    Lacy, Katie E.
    Wells, Claire M.
    ONCOTARGET, 2016, 7 (43) : 70881 - 70897
  • [36] Advances in the 1-phenanthryl-tetrahydroisoquinoline series of PAK4 inhibitors: potent agents restrain tumor cell growth and invasion
    Hao, Chenzhou
    Li, Xiaodong
    Song, Shuai
    Guo, Bingyu
    Guo, Jing
    Zhang, Jian
    Zhang, Qiaoling
    Huang, Wanxu
    Wang, Jian
    Lin, Bin
    Cheng, Maosheng
    Li, Feng
    Zhao, Dongmei
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2016, 14 (32) : 7676 - 7690
  • [37] P21-activated kinase 4 (PAK4) as a predictive marker for gemcitabine in pancreatic cancer cell line
    Moon, Sung Ung
    Kim, Jin Won
    Sung, Ji Hea
    Kang, Mi Hyun
    Chang, Hyun
    Lee, Jeong Ok
    Kim, Yu Jung
    Lee, Keun Wook
    Kim, Jee Hyun
    Bang, Soo Mee
    Lee, Jong Seok
    CANCER RESEARCH, 2014, 74 (19)
  • [38] Novel signaling pathways in cancer cells and development of targeted cancer therapy
    Hung, MC
    ONCOLOGY RESEARCH, 2006, 15 (10-12) : 456 - 456
  • [39] Signaling pathways responsible for cancer cell invasion as targets for cancer therapy
    Sliva, D
    CURRENT CANCER DRUG TARGETS, 2004, 4 (04) : 327 - 336
  • [40] Activated PAK4 regulates cell adhesion and anchorage-independent growth
    Qu, J
    Cammarano, MS
    Shi, Q
    Ha, KC
    De Lanerolle, P
    Minden, A
    MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (10) : 3523 - 3533
12345